Reaction
Optic Atrophy reporting signals
As of the last recalculation, Optic Atrophy appears in 1,618 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is VIGABATRIN (PRR 48.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vigabatrin | 53 | 48.3 | 48.5 |
| Isoniazid | 28 | 22.6 | 22.6 |
| Cefuroxime | 17 | 19.3 | 19.3 |
| Rifampicin | 15 | 19.2 | 19.3 |
| Minocycline | 17 | 18.9 | 19.0 |
| Ganciclovir Sodium | 14 | 17.2 | 17.2 |
| Quinine | 11 | 16.6 | 16.6 |
| Ganciclovir | 13 | 16.5 | 16.5 |
| Thiotepa | 12 | 16.3 | 16.3 |
| Pyrazinamide | 11 | 15.2 | 15.2 |
| Calcium Gluconate | 13 | 14.0 | 14.0 |
| Fingolimod Hcl | 88 | 13.8 | 13.8 |
| Brinzolamide | 9 | 13.4 | 13.4 |
| Faricimab | 8 | 12.8 | 12.8 |
| Bleomycin Sulfate | 10 | 12.5 | 12.5 |
| Lamivudine Oral | 23 | 11.8 | 11.9 |
| Zidovudine | 12 | 11.6 | 11.6 |
| Dorzolamide Hydrochloride And Timolol Maleate | 7 | 11.4 | 11.4 |
| Norepinephrine Bitartrate | 12 | 10.8 | 10.8 |
| Lamivudine | 25 | 10.6 | 10.6 |
| Prednisolone Acetate | 8 | 10.0 | 10.0 |
| Melphalan Hydrochloride | 19 | 9.9 | 9.9 |
| Dextrose | 10 | 9.8 | 9.8 |
| Ranibizumab | 20 | 9.8 | 9.8 |
| Dextrose Monohydrate | 10 | 9.7 | 9.7 |
| Tenofovir Disoproxil Fumarate Tablets | 6 | 9.0 | 9.0 |
| Melphalan | 15 | 8.6 | 8.6 |
| Norepinephrine | 7 | 8.5 | 8.5 |
| Rifampin | 9 | 8.0 | 8.0 |
| Linezolid | 17 | 7.4 | 7.4 |
| Brimonidine Tartrate | 8 | 5.8 | 5.8 |
| Etoposide | 32 | 5.7 | 5.7 |
| Temozolomide | 9 | 5.5 | 5.5 |
| Carboplatin | 50 | 5.2 | 5.2 |
| Dalfampridine | 21 | 3.8 | 3.8 |
| Aflibercept | 9 | 3.7 | 3.7 |